ADAR1 Capital Management reports acquisition of $53,691.3221 in NextCure common shares

• ADAR1 Capital Management reported purchases of 10,851 NextCure common shares, increasing indirect beneficial ownership to 733,270 shares.
• The purchases comprised 5,626 shares at $4.8294, 1,672 shares at $5.0344 and 3,553 shares at $5.0953.
• Daniel Schneeberger, ADAR1’s manager, jointly reported the transactions. Both reporting owners are listed as 10% owners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000029), on October 27, 2026, and is solely responsible for the information contained therein.